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Role of p53 in pseudorabies virus replication, 
pathogenicity, and host immune responses
Xun Li1†, Wei Zhang2†, Yunjia Liu1, Jiaxun Xie1, Chuanhuo Hu1 and Xiaoye Wang1*
Abstract 
As a key cellular transcription factor that plays a central role in cellular responses to a broad range of stress factors, p53 
has generally been considered as a host cell restriction factor for various viral infections. However, the defined roles 
of p53 in pseudorabies virus (PRV) replication, pathogenesis, and host responses remain unclear. In the present study, 
we initially constructed a p53 overexpressing a porcine kidney epithelial cell line (PK-15) to detect the effect of p53 on 
PRV replication in vitro. The results show that viral glycoprotein B (gB) gene copies and the titers of virus were sig-
nificantly higher in p53 overexpressing PK-15 cells than in PK-15 and p53 inhibitor treated p53 overexpressing PK-15 
cells. A similar result was also found in the p53 inhibitor PFT-α-treated PK-15 cells. We then examined the effects of 
p53 on PRV infection in vivo by using p53-knockout  (p53−/−) mice. The results show that p53 knockout not only led 
to significantly reduced rates of mortality but also to reduced viral replication and development of viral encephalitis 
in the brains of mice following intracranial inoculation. Furthermore, we examined the effect of p53 knockout on the 
expression of the reported host cell regulators of PRV replication in the brains of mice by using RNA sequencing. The 
results show that p53 knockout downregulated the interferon (IFN) regulator genes, chemokine genes, and antiviral 
genes after PRV infection. This finding suggests that p53 positively regulates viral replication and pathogenesis both 
in vitro and in vivo. These findings offer novel targets of intrinsic host cell immunity for PRV infection.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Pseudorabies virus (PRV) belongs to the genus Varicell-
ovirus in the subfamily Alphaherpesvirinae and it is the 
pathogen that causes porcine Aujeszky’s disease (AD) [1]. 
PRV causes nervous and respiratory system disorders in 
newborn piglets and reproductive failure in sows [2]. The 
virus has a broad host range and can infect most mam-
mals; however, pigs are the natural reservoir and the only 
animal that can survive PRV infection [1]. The clinical 
manifestations of other animals infected by PRV are fatal 
and acute, and accompanied by extreme itching.
The tumor suppressor protein p53 is a major host cel-
lular response protein to a broad range of stress factors 
such as viral infection through its modulation of cel-
lular pathways, including innate immune control, host 
cell cycling, proliferation, DNA repair, and apoptosis 
[3–5]. Viral infection is a type of cellular stress that acti-
vates p53 response that triggers apoptosis of the infected 
cells, leading to the suppression of viral replication [6–8]. 
Thus, p53 is considered as a host restriction factor in a 
range of viral infections. However, p53 appears to have 
both positive and negative effects on various viral infec-
tions. The replication of various viruses is enhanced by 
the knockout or knockdown of p53 and inhibited by the 
overexpression of p53. Examples of such viruses include 
hepatitis C virus (HCV), influenza A virus (IAV), Japa-
nese encephalitis virus (JEV), and vesicular stomatitis 
virus (VSV) [6, 8, 9]. Furthermore, many viruses have 
acquired a variety of distinct mechanisms to counter-
act the negative effects of p53 in infected cells [6]. Con-
versely, p53 is required for efficient viral replication of 
other viruses. p53 knockdown impairs the replication of 
herpes simplex virus 1 (HSV-1) and the associated viral 
pathogenesis of the central nervous system (CNS) of 
mice [10, 11]. It was also reported that the replications of 
human cytomegalovirus (HCMV) and porcine circovirus 
type 2 were impaired by p53 knockdown [12, 13].
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Collectively, the studies described above indicate that 
p53 is a critical host restriction factor for a variety of 
viruses. However, there are no studies that have exam-
ined the effects of p53 on PRV infection. The biological 
significance of p53 in PRV replication, pathogenicity, and 
host immune responses remains to be elucidated. In the 
present study, we investigated the role(s) of p53 in PRV 
replication by using p53 overexpressing PK-15 cells and 
the p53 inhibitor PFT-α-treated PK-15 cells in vitro. Fur-
thermore, we investigated the effects of p53 on the rep-
lication and pathogenesis of PRV in  vivo by using p53 
knockout mice. The primary aim of this study was to 
elucidate the underlying mechanisms responsible for the 
role of p53 involvement in the replication and pathogen-
esis of PRV and to offer novel targets of intrinsic host cell 
immunity for PRV infection.
Materials and methods
Cells, mice, and virus
The PK-15 cell line was purchased from the American 
Type Culture Collection (ATCC, Rockville, MD, USA). 
The cells were grown in Dulbecco’s Modified Eagle’s 
medium (DMEM, Wisent) supplemented with 10% fetal 
bovine serum (FBS, Invitrogen, Carlsbad, CA, USA) and 
80 μg of gentamycin/mL at 37 °C in a humidified atmos-
phere of 5%  CO2.
A p53 overexpressing PK-15 cell line (PK-15 pCDH-
p53) was constructed and maintained in our labora-
tory. The p53 gene (GenBank No.AF098607.1) was 
synthesized and cloned into pCDH-CMV-MCS-
EF1-CopGFP-T2A-Puro (pCDH-MCS-GFP-Puro) to 
generate the recombinant lentiviral vector pCDH-CMV-
p53-EF1-CopGFP-T2A-Puro (pCDH-p53-GFP-Puro). 
The insertion fragment was identified by polymerase 
chain reaction (PCR), restriction endonuclease analysis, 
and DNA sequencing. The plasmid lentiviral vector sys-
tem was transfected into PK-15 cells with Lipofectin 2000 
reagent for packaging into mature lentivirus. Polybrena 
was used to screen stably expressing p53 PK-15 cells. An 
empty lentiviral vector was also transfected into PK-15 
cells as the negative control (PK-15 pCDH). After 48 h of 
transfection, the cells were collected and stored at −80 °C 
until the expression level of p53 was measured by real-
time PCR and Western blot.
p53 knockout  (p53−/−) mice and wild-type mice litter-
mates were obtained by interbreeding heterozygous mice 
(stock number B-EM-020), provided by the Beijing Bio-
cytogen Co., Ltd.
The PRV strain Bartha K61 was isolated and purified 
from vaccine (Jiangsu Nannong Gaoke Animal Phar-
maceutical Co., Ltd.) and maintained in our laboratory. 
PK-15 was used for the propagation of PRV.
Cell studies
PK-15  p53+/+ cells were infected with 0.1 multiplicity 
of infection (MOI) PRV. At 8, 12, 24, and 48  h post-
infection, the cells were harvested to detect the viral 
titer, and glycoprotein B (gB) mRNA expression of PRV 
utilized real-time PCR and 50% tissue culture infective 
dose  (TCID50), respectively.
PK-15 cells were treated with PFT-α (p53 inhibi-
tor) and then infected with 0.1 MOI of PRV. The cells 
were also harvested to detect the gB mRNA expres-
sion of PRV by real-time PCR at 8, 12, 24, and 48  h 
post-infection.
Animal studies
All the animal experiments and the protocols used in 
this study were approved by the Research Ethics Com-
mittee of the College of Animal Science, Guangxi Uni-
versity, Guangxi, China. The animals were maintained 
under constant conditions of light (12  h of light) and 
temperature (22 °C) and housed in groups of four mice 
per cage until the beginning of the tests. The mice, had 
free access to pelleted food and tap water. For intrac-
ranial infection, 4- to 8-week-old male  p53−/− mice 
(n = 40) and wild-type mice (n = 40) were injected 
intracranially with  105  TCID50 of PRV (Bartha). Fif-
teen mice among the total of either  p53−/− or wild-
type mice were monitored daily, and the mortality was 
recorded from 1 to 14 days post-infection. Twenty-five 
mice among the total  p53−/− or wild-type mice were 
killed at 6 days after infection by decapitation under a 
mild dose of anesthetic ether within 30 min. The brains 
were excised and cleaned. Twelve brains of  p53−/− or 
wild-type mice were stored at −80 °C to detect the host 
cellular gene expression by RNA sequencing. Six brains 
of  p53−/− or wild-type mice were stored at −80  °C to 
detect the viral titer as well as the expression of the 
gB gene and inflammatory factors by using  TCID50 
and real-time PCR, respectively. Blood serum was also 
collected and kept at 4  °C to detect the inflammatory 
factor through specific antibodies by enzyme-linked 
immunosorbent assay (ELISA). The other 7 brains of 
 p53−/− or wild-type mice were fixed in neutral-buffered 
formalin for histological analysis.
Histopathology
For histological analysis, the brains were dehydrated 
in an ethanol series and embedded in paraffin wax, 
followed by histologic sectioning (5  μm) and routine 
hematoxylin–eosin staining. To describe the histopa-
thology in the brain in the  p53−/− and  p53+/+ mice, 
the pathological changes were determined through 
observation of the morphologic characteristics. For 
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this purpose, 5 slides were selected from 1 sample, and 
2 sections from each slide were examined microscopi-
cally (magnification: ×400).
RNA extraction and real‑time reverse transcription PCR 
(RT‑PCR)
Total RNA from the brains or cells was extracted using 
the TRIzol extraction method (TRIzol reagent, TaKaRa 
Japan). The procedures for RNA isolation and purifi-
cation, as well as the on-column deoxyribonuclease 
treatment (Qiagen), were performed according to the 
manufacturer’s instructions. For each sample, equal 
amounts of all the RNA samples were reverse transcribed 
simultaneously using an oligo (deoxythymidine) 15 
primer and M-MLV reverse transcriptase (TaKaRa Japan) 
according to the manufacturer’s instructions. All RT 
reactions were performed at 42 °C and included a nega-
tive control, which contained nuclease-free water instead 
of RNA. The SYBR Green Quantitative Real-Time PCR 
Master Mix (Roche, Mannheim, Germany) was used to 
quantify or relatively quantify the abundance of the tar-
get mRNA according to the manufacturer’s instructions, 
and the accumulated fluorescence was detected using a 
real-time PCR detection system (Prism 7300, Applied 
Biosystems Inc., Foster City, USA). The primer sequences 
are shown in Table 1. β-Actin served as the endogenous 
control. The real-time PCR amplification conditions were 
as follows: initial denaturation at 95  °C for 10  min, fol-
lowed by 40 cycles of 95  °C for 20  s, annealing for 30  s 
at 59–61  °C, and then extension at 72  °C for 30  s. To 
quantify the viral load, the PRV viral gB mRNA level was 
determined by absolute quantification real-time PCR. 
The gB gene was constructed from the pMD-19T vec-
tor (Promega, Madison, WI, USA) and termed pMD-
gB. A standard graph of the  CT values was constructed 
from a tenfold serial dilution of the pMD-gB. The  CT val-
ues from the test samples were plotted on the standard 
curve, and the copy number was calculated automatically 
by Sequence Detector version 1.6 (PE Applied Biosys-
tems), a software package for data analysis. Each sample 
was tested in duplicate, and the mean of the two values 
was considered as the copy number of the sample. The 
expression levels of the other target genes were meas-
ured by relative quantitative real-time PCR. The data for 
each sample were calculated using the  2−ΔΔCT method as 
described previously.
RNA sequencing
For RNA sequencing analysis, equal amounts of the 
total RNA from either the  p53−/− or wild-type mice 
(n = 12) were pooled into one sample. The procedure 
used for RNA sequencing has been described previ-
ously. Briefly, sequencing libraries were constructed 
with the SureSelect Strand-Specific RNA library (Agi-
lent); 100-bp paired-end sequencing was performed 
using an Illumina HiSeq  2500 sequencer according to 
the manufacturer’s instructions. The raw sequence 
reads were mapped to the mouse genome by using the 
TopHat program. The normalized transcription pro-
files were estimated on the basis of the mapping results 
using the Cufflinks program.
The number of reads per kilobase of exon per mil-
lion mapped reads (RPKM) was converted from the 
Table 1 Primers and annealing temperature for real-time 
PCR. 
Genes Primer sequence (5′‑3′) Annealing (°C)
gB (F)CGG CAT CGC CAA CTT CTT C
(R)GTC CTC CTT GAG CGT CTT CGT 
61
IL-6 (F)AGT CCG GAG AGG AGA CTT CA
(R)ATT TCC ACG ATT TCC CAG AG
60
TNF-α (F)GGG ACA GTG ACC TGG ACT GT
(R)GCT CCA GTG AAT TCG GAA AG
61
Oasl2 (F)ACA ATT TCC AAA ACG AGG TC
(R)TTC CCA TCC CTT TCT TCT TC
59
Ifi44 (F)GAC AGA TAC CAG TTC GAT TC
(R)TTT TCT TGA TCT TTG CCA CC
60
Usp18 (F)CAA GGA ACA GTC TGA AAT ACAC 
(R)CAC AGT AAT GAC CAA AGT CAG 
60
Ifit1 (F)AGA ACA GCT ACC ACC TTT AC
(R)TTC TTG ATG TCA AGG AAC TG
61
Ly6a (F)GAG AGG AAG TTT TAT CTG TGC 
(R)TCT CAA ATG GGA CTC CAT AG
60
Gbp10 (F)CTA ACC GGA AGT GTT TTG TC
(R)CAG AAT CCC TAG TTT ATT CCC 
59
Gbp4 (F)AGC TAA CGA AGG AAC AAA AG
(R)GAT GTT ATG TCC CAG TTG ATG 
60
Gbp3 (F)CTG TTC GAG ATT TTG CTC TG
(R)TGG ACT TTG AGA TTG TCT CC
60
Gbp7 (F)GAG TGA AGG CAA ATC ATG TC
(R)CTG TTT CTG TCT TAG TAG CTC 
60
Stat1 (F)TTT GAC AGT ATG ATG AGC AC
(R)AGC AAA TGT GAT GCT CTT TC
61
Ddx58 (F)GAG AGT CAC GGG ACC CAC T
(R)CGG TCT TAG CAT CTC CAA CG
61
Ifih1 (F)TGA TGC ACT ATT CAA GAA CTA ACA 
(R)TCT GTG AGA CGA GTT AGC CAAG 
59
Ifitm3 (F)TCA TCA TTG TTC TTA ACG CTCA 
(R)CGG AAG TCG GAA TCC TCT AT
60
Mx1 (F)GAA GGC AAG GTC TTG GAT G
(R)GCT GAC CTC TGC ACT TGA CT
60
Ifi44 (F)TTC AAC TCA GTG GAA GTC TGCT 
(R)GGA GTG TTT CCC CGC TTT TTC 
61
Ccl2 (F)TCT GTG CTG ACC CCA AGA AGG 
(R)TGG TTG TGG AAA AGG TAG TGGAT 
59
Cxcl10 (F)TCC CTC TCG CAA GGAC 
(R)TTG GCT AAA CGC TTT CAT 
59
β-actin (F)AGG TGA CAG CAT TGC TTC TG
(R)GCT GCC TCA ACA CCT CAA C
60
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row read counts of each transcript using the program 
Cuffdiff.
Elisa
Levels of the cytokines interleukin (IL)-6 and tumor 
necrosis factor (TNF)-α were measured by ELISA using 
the mouse IL-6 and TNF-α kits (Biosource). Blood 
samples were collected, and serum was separated. The 
serum was then added to wells coated with monoclonal 
antibodies against IL-6 and TNF-α. After 3 washes with 
washing buffer (0.05% Tween-20 in phosphate-buffered 
saline, PBS), peroxidase-conjugated avidin, biotinylated 
antibodies against IL-6 and TNF-α, and chromogenic 
substrates were added to each well. The absorbance was 
read at 450 nm in an ELISA plate reader.
Virus infection and titration
PRV was propagated in PK-15 cells in DMEM supple-
mented with 10% FBS until harvested. Then, viral stock 
titers were measured using the plaque-forming unit 
(PFU) assay, and  TCID50 was calculated using the Reed-
Muench method.
Statistical analysis
All the data are shown as mean ± S.E.M. The differences 
were considered to be significant when P < 0.05. Statisti-
cal analysis was performed using one-way analysis of var-
iance (ANOVA) with SPSS 17.0.
Results
p53 facilitates PRV viral replication in vitro
gB is the most conserved envelope glycoprotein across 
the herpesvirus family. Because of its indispensable 
role in fusion during virus entry and cell-to-cell viral 
spread, it is required for viral replication. To investi-
gate the effect of p53 on PRV replication in  vitro, we 
estimated the viral load and virus yield by quantifica-
tion real-time PCR and  TCID50 assays in PFT-α (p53 
inhibitor) treated PK-15 pCDH-p53 and PK-15 pCDH-
p53 cells compared with PK-15 pCDH. As shown in 
Figure 1A, the viral gB gene copies gradually increased 
from 4  h to 24  h in PFT-α treated PK-15 pCDH-p53, 
PK-15 pCDH-p53 and PK-15 pCDH cells, but the 
viral load in PK-15 pCDH-p53 cells exceeded that in 
PK-15 pCDH and PFT-α treated PK-15 pCDH-p53 
cells in 8  h, 12  h, and 24  h. The viral gB gene copies 
show no significant difference between PFT-α treated 
PK-15 pCDH-p53 and PK-15 pCDH cells. The results 
of viral titers were consistent with the viral load test 
(Figure 1B). To further confirm the promotive effect of 
p53 on PRV viral replication, PK-15 cells treated with 
PFT-α were also used to estimate the virus yield after 
PRV infection compared with mock PK-15 cells. The 
results show that PFT-α-treated PK-15 cells exhibited 
significantly lower viral gB gene copies (Figure  1C) 
and viral titers (Figure  1D) than mock PK-15 cells. 
These results indicate that p53 facilitates PRV viral 
Figure 1 Effect of p53 on the PRV replication in vitro. A The viral 
gB gene copies were detected in PFT-α (p53 inhibitor) treated PK-15 
pCDH-p53, PK-15 pCDH-p53 and PK-15 pCDH cells after 0.1 MO PRV 
infection in 4, 8, 12, and 24 h by quantitative real-time PCR. B Titers 
of PRV were determined in PFT-α treated PK-15 pCDH-p53, PK-15 
pCDH-p53 and PK-15 pCDH cells after 0.1 MO PRV infection in 4, 8, 
12, and 24 h by  TCID50. C The viral gB gene copies were detected in 
PFT-α treated PK-15 and mock PK-15 cells after 0.1 MO PRV infection 
in 4, 8, 12, and 24 h by quantitative real-time PCR. D Titers of PRV were 
determined in PFT-α treated PK-15 and mock PK-15 cells after 0.1 
MO PRV infection in 4, 8, 12, and 24 h by  TCID50. All the results were 
confirmed by three independent experiments. Error bars represent 
the standard deviations of triplicate experiments. *P < 0.05; **P < 0.01.
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replication by increasing gB expression and PRV prog-
eny yields in vitro.
p53 promoted the PRV replication in mice brain in vivo
Because PRV infection mainly causes neurological symp-
toms, in order to investigate the role of p53 in PRV rep-
lication in vivo, we detected the mortality, viral load, and 
viral yield in the brains of wild-type and  p53−/− mice. The 
survival of the infected mice was monitored for 14 days 
post-infection. As shown in Figure 2A, the survival rate 
of the  p53−/− mice was 100%, while the survival rate of 
wild-type mice was only 53%, suggesting that  p53−/− 
mice are susceptible to PRV infection. Another group of 
wild-type and  p53−/− mice were infected as described 
above. The virus titers and viral gB gene in the brains 
were assayed at 6 days post-infection. The viral titers in 
the brains of the wild-type mice were significantly higher 
than those in the brains of the  p53−/− mice (Figure 2B). 
The PRV gB gene copy numbers of the wild-type mice 
were nearly tenfold that of the  p53−/− mice, which was 
consistent with the viral titers (Figure  2C). The above 
results indicate that knockout of p53 inhibited PRV rep-
lication in mouse brains; this implies that p53 promoted 
PRV replication in vivo. In summary, these findings fur-
ther reveal that p53 facilitates PRV viral replication both 
in vitro and in vivo.
p53 promoted PRV infection pathogenicity in mice
Encephalitis caused by PRV infection in the CNS is a 
key factor contributing to animal death. To detect the 
degree of encephalitis in wild-type and  p53−/− mice, we 
histopathologically analyzed the brains at 6  days post-
infection. As shown in Figure  3, the brains of the wild-
type mice show a significant increase in the number of 
necrotic neurons (Figure  3I), and more glial cells were 
accumulated around the degenerate neurons (glial nod-
ules) than those in  p53−/− mice (Figure 3D). Additionally, 
neuronophagia was found in the brains of the wild-type 
mice (Figure 3I). In the cerebellum of the wild-type mice, 
a large number of Purkinje cells show shrinkage or necro-
sis (Figure 3K) and more obvious nuclear disintegration 
(Figure  3K) than that in the cerebellum of  p53−/− mice 
(Figure  3E). Furthermore, perivascular cuffing (Fig-
ure 3O) and hyperemia (Figure 3M) were more obvious 
in the brains of wild-type mice.
We further determined IL-6 and TNF-α mRNA and 
protein levels in the brains of the wild-type and  p53−/− 
mice by relative quantitative real-time PCR and ELISA. 
The results show that both IL-6 and TNF-α mRNA 
expression levels in the brains of the wild-type mice were 
significantly higher (80-fold and eightfold, respectively) 
than those in the  p53−/− mice (Figures  4A  and B). A 
Figure 2 Effect of p53 on PRV replication in mice brains in vivo. 
Four- to 8-week-old male  p53−/− mice (n = 15) and wild-type mice 
(n = 15) were inoculated with  105  TCID50 of PRV (Bartha) intracranially. 
A The survival of the infected  p53−/− and wild-type mice was 
monitored for 14 days post-infection. Statistical significance was 
determined by the log-rank test. B, C At 5 days post-infection, the 
brains of the infected mice were harvested. Viral gB gene copies 
and virus titers in the brains of the  p53−/− and wild-type mice were 
assayed by quantitative real-time PCR and  TCID50, respectively. Each 
data point is the viral titer or viral gB gene copies in the brain of 
one mouse. The horizontal bars indicate the mean for each group. 
*P < 0.05; **P < 0.01.
Page 6 of 12Li et al. Vet Res            (2019) 50:9 
similar result was also found in protein levels. The pro-
tein levels of IL-6 and TNF-α were significantly higher in 
the brains of the wild-type mice than those in the  p53−/− 
mice (Figures  4C  and D); this finding suggests that the 
wild-type mice experienced a more severe inflammatory 
response than the  p53−/− mice. These results indicate 
that p53 promotes the pathogenicity of PRV infection 
in vivo.
p53 knockout suppresses the inflammatory response 
in the brains of infected mice
To investigate the effects of p53 knockout on the host 
cell gene expression in the brains of the infected mice, we 
performed a whole-transcriptome shotgun sequencing 
analysis of the brains from the infected  p53−/− and wild-
type mice following intracranial infection. In the expres-
sion profiles, 122 mRNA were differentially expressed, 
comprising 104 downregulated and 18 upregulated 
mRNA (Figure  5A). A functional annotation analysis of 
the target genes of the differentially expressed mRNA was 
performed to identify the gene ontology (GO) terms and 
the Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathways. As shown in Figure  5B, most of the enriched 
GO terms of the differentially expressed mRNA were 
involved in GTPase activity, GTP binding, and guanyl 
ribonucleotide binding molecular functions as well as the 
immune response and immune system process. KEGG 
pathway enrichment analysis indicates that the differ-
entially expressed genes (DEG) tended to be involved in 
herpes simplex infection, ribosome and antigen process-
ing and presentation as well as TNF signaling and Toll-
like receptor signaling pathways (Figure 5C).
Furthermore, the downregulated genes of the DEG 
were further grouped according to their functions. The 
results show that compared to the wild-type mice, the 
major downregulated genes included the IFN-related 
genes, chemokines, and antiviral genes. As shown in 
Figure 3 Histopathological features of the brains of the p53−/− 
and wild‑type mice following intracranial inoculation. Four- to 
8-week-old male  p53−/− (n = 7) and wild-type (n = 7) mice were 
inoculated with  105  TCID50 of PRV (Bartha) intracranially. At 6 days 
post-infection, the brains of the infected mice were harvested, 
sectioned, and stained with hematoxylin and eosin. B, C Magnified 
images of the regions indicated with black rectangles in A. G, H 
Magnified images of the regions indicated with black rectangles in 
F. D, E, I, K, M, and O Magnified images of the regions indicated with 
black rectangles in B, C, G, H, L, and N, respectively. Representative 
images are shown. N: neurons; G; glial cells; NN: necrotic neurons; NP: 
neuronophagia; P: Purkinje cells; PS: shrinkage of Purkinje cells; PN: 
necrotic Purkinje cells; ND: nuclear disintegration of Purkinje cells; H: 
hyperemia; and PC: perivascular cuffing.
▸
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Table  2, the levels of IFN signal pathway-related fac-
tors 1 and 7 (IRF1 and IRF7) in the brains of the  p53−/− 
mice were reduced 8.0- and 25.4-fold, respectively, 
compared to those in the brains of wild-type mice. 
Further, compared with those in the wild-type mice, 
the IFN-induced protein family genes (Ifit1, Ifit2, Ifit3, 
Ifit3b, Ifitm3, Ifip1, Ifih1, Ifi44, and Ifi2712a) in the 
 p53−/− mice were significantly downregulated, with 
a fold change ranging from 5.7 to 38.2. Similarly, the 
guanylate-binding protein family genes, which belong 
to another IFN-induced family, including Gbp 2, Gbp 
3, Gbp 4, Gbp 5, Gbp 6, Gbp 7, Gbp 8, Gbp 9, and Gbp 
10, were decreased, with a fold change ranging from 6.4 
to 38.2. Chemokines are considered to be pro-inflam-
matory agents and can be induced during an immune 
response to recruit cells of the immune system to the 
site of infection. As shown in Table  3, the chemokine 
gene family, including Ccl2, Ccl7, Cxcl9, and Cxcl10, 
Figure 4 IL‑6 and TNF‑α mRNA and antibody levels were detected in the brains of the p53−/− and wild‑type mice following intracranial 
inoculation. Four- to 8-week-old male  p53−/− (n = 6) and wild-type (n = 6) mice were inoculated with  105  TCID50 of PRV (Bartha) intracranially. At 
6 days post-infection, the brains of the infected mice were harvested (A–D). IL-6 and TNF-α mRNA and antibody levels were detected by relative 
quantitative real-time PCR and ELISA. Each data point is the level of IL-6 and TNF-α mRNA or antibodies in the brain of one mouse. The horizontal 
bars indicate the mean for each group. *P < 0.05; **P < 0.01.
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Figure 5 GO terms and KEGG pathway enrichment analysis of the DEG mRNA. A The volcano plot for the DEG between the brains of 
 p53−/− and wild-type mice; the x-axis indicates the log fold change and the y-axis indicate the -log (P value). B The most enriched terms for 
the differentially expressed mRNA are displayed here. The enrichment score of the GO term equals the -log10 (P-value). The listed GO items are 
categorized as biological processes or molecular functions. C The rich factor plot of the KEGG pathway enrichment analysis results. The degree of 
the color stands for the P-value; the size of the node stands for the gene count in this item.
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was found to be downregulated, with a fold change 
ranging from 44.2 to 133.9. As shown in Table  4, the 
antiviral genes of the  p53−/− mice related to the IFN 
pathways were downregulated, with fold changes rang-
ing from 3.0- to 76.9-fold; for example, the expression 
of genes encoding virus entry inhibitors such as Mx1 
reduced 76.9-fold and that of genes encoding virus 
translation and replication inhibitors such as Oasl1 and 
Oasl2 was reduced 68.0- and 9.3-fold, respectively.  
To validate the data obtained by RNA sequencing 
analysis, 16 downregulated genes were selected and 
their expression was detected by relative quantita-
tive real-time PCR. As shown in Figure  6, the expres-
sion levels of the 16 genes (Oasl2, Ddx58, Mx1, Stat1, 
Gbp3, Gbp4, Gbp7,Gbp10, Ifih1, lfitm3, Ifi44, Ifit1, 
Ccl2, Cxcl10, Ly6a, Usp18) in the  p53−/− mice were sig-
nificantly decreased compared to those in the wild-type 
mice. These results were consistent with the findings of 
RNA sequencing analysis.
Discussion
PRV causes encephalitis that can result in severe neuro-
logical defects and death in swine. Many of the host cell 
factors involved in the regulation of PRV infection have 
been investigated. However, most of these factors are 
immunological regulators and function through immu-
nological pathways to restrict PRV infection. These 
factors therefore provide limited information on the 
intrinsic host cell regulators that may be involved in the 
facilitation of PRV infection. Here, we demonstrate that 
a host cell protein, p53, which has generally been con-
sidered as a host cell restriction factor for various viral 
infections, is required for efficient PRV replication and 
pathogenesis in mice. This is the first report showing 
that p53 positively regulates PRV replication and patho-
genesis in vitro and in vivo and provides insights into the 
molecular mechanism of p53.
Table 2 Differential expressed of IFN-related genes in brains of PRV-infected p53−/− and wild-type mice. 
a  Fold activation represents the fold increase in the level of activation in  p53−/− mice compared with the level of activation in wild-type mice.
Gene ID Gene name Gene description Foldchangea
(p53−/− vs 
wild‑type)
16362 Irf1 Interferon regulatory factor 1 −8.0
54123 Irf7 Interferon regulatory factor 7 −25.4
15957 Ifit1 Interferon-induced protein with tetratricopeptide repeats 1 −19.6
15958 Ifit2 Interferon-induced protein with tetratricopeptide repeats 2 −12.4
15959 Ifit3 Interferon-induced protein with tetratricopeptide repeats 3 −12.9
667370 Ifit3b Interferon-induced protein with tetratricopeptide repeats 3b −10.4
66141 Ifitm3 Interferon induced transmembrane protein 3 −5.7
60440 Iigp1 Interferon inducible GTPase 1 −37.7
71586 Ifih1 Interferon induced with helicase C domain 1 −7.5
99899 Ifi44 Interferon-induced protein 44 −17.6
76933 Ifi27l2a Interferon alpha-inducible protein 27 like 2A −9.5
14469 Gbp2 Guanylate binding protein 2 −38.2
55932 Gbp3 Guanylate binding protein 3 −13.3
17472 Gbp4 Guanylate binding protein 4 −31.7
229898 Gbp5 Guanylate binding protein 5 −26.8
100702 Gbp6 Guanylate binding protein 6 −12.0
229900 Gbp7 Guanylate binding protein 7 −6.4
236573 Gbp9 Guanylate binding protein 9 −8.0
626578 Gbp10 Guanylate binding protein 10 −24.6
Table 3 Differential expressed chemokines in brains of 
PRV-infected p53−/− and wild-type mice. 
a  Fold activation represents the fold increase in the level of activation in  p53−/− 
mice compared with the level of activation in wild-type mice.
Gene ID Gene name Gene description Foldchangea
(p53−/− 
and wild‑
type)
20296 Ccl2 Chemokine (C–C motif ) ligand 2 −65.7
20306 Ccl7 Chemokine (C–C motif ) ligand 7 −42.2
17329 Cxcl9 Chemokine (C-X-C motif ) 
ligand 9
−75.1
15945 Cxcl10 Chemokine (C-X-C motif ) ligand 
10
−133.9
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Animals usually have many defense strategies against 
viral infection; however, viruses have evolved complex 
tactics to override these lines of defense, for instance, 
by using the host defensive proteins to promote viral 
replication [14–16]. p53 is a critical host restriction fac-
tor because its regulation of the various cellular life pro-
cesses, such as cell cycle arrest, apoptosis, and autophagy 
[6], has both positive and negative effects on various 
viral infections [10, 12]. On the basis of previous stud-
ies, double-stranded RNA are produced in RNA virus 
infections, and these double-stranded RNA trigger anti-
viral responses mediated by type I interferon (IFN-I) 
signaling, in which p53 appears to reduce the replication 
of some viruses; therefore, these viruses have acquired 
mechanisms to counteract p53 in infected cells [7, 8]. 
However, in DNA virus infection, viral genome replica-
tion induces host DNA damage responses (DDRs), which 
activate apoptotic p53 responses [6, 10]. In agreement 
with these observations, we found that p53 overexpres-
sion promoted PRV replication, whereas inhibiting p53 
by a specific inhibitor reduced PRV replication in PK-15 
cells in  vitro.  p53−/− mice were also not susceptible to 
PRV infection compared to wild-type mice in vivo. Fol-
lowing intracranial inoculation, p53 knockout reduced 
viral replication in the brains of mice and led to signifi-
cantly reduced rates of mortality. However, PRV titers 
and viral gene copy numbers in the brain as well as mor-
tality after intracranial inoculation appear to be surpris-
ingly low. The possible reason is that the attenuated PRV 
vaccine strain (PRV-Bartha) which was used for intracra-
nial inoculation in our studies. Brittle et al. [17] reported 
that mice infected with an attenuated PRV vaccine strain 
(PRV-Bartha) survive approximately three times longer 
than virulent (e.g., PRV-Becker, PRVKaplan, or PRV-
NIA3) strain-infected mice. Furthermore, they indicated 
that the absence of the genes encoding US9, gE and gI 
in PRV-Bartha accounts for much of its attenuation. The 
absence of US9, gE and gI genes led to the time delay of 
PRV-Bartha entering various tissue types. In addition, 
the amount of infectious PRV-Bartha in the brainstem 
was lower relative to virulent PRV at the equivalent time 
point. Taken together, these results suggest that p53 has 
a positive effect on PRV replication both in  vitro and 
in vivo.
It has previously been reported that PRV invades 
and spreads within the trigeminal pathway (the nasal 
mucosa, the trigeminal ganglion, the pons/medulla, and 
the cerebellum/thalamus) of neonatal pigs [18, 19]. PRV 
induces encephalitis in both pigs and mice with similar 
Table 4 Differential expressed anti-viral genes in brains of PRV-infected p53−/− and wild-type mice. 
a  Fold activation represents the fold increase in the level of activation in  p53−/− mice compared with the level of activation in wild-type mice.
Gene ID Gene name Gene description Foldchangea
(p53−/− 
and wild‑
type)
20846 Stat1 Signal transducer and activator of transcription 1 −3.0
53817 Ddx39b DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B −14.8
230073 Ddx58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 −5.6
20210 Saa3 Serum amyloid A 3 −44.0
110454 Ly6a Lymphocyte antigen 6 complex locus A −3.8
100041546 Ly6c2 Lymphocyte antigen 6 complex locus C2 −23.0
231655 Oasl1 2′-5′ oligoadenylate synthetase-like 1 −68.0
23962 Oasl2 2′-5′ oligoadenylate synthetase-like 2 −9.3
17857 Mx1 MX dynamin-like GTPase 1 −76.9
58185 Rsad2 Radical S-adenosyl methionine domain containing 2 −37.1
Figure 6 The expression levels of the 16 downregulated genes 
of the p53‑/‑ mice were detected by relative quantitative 
real‑time PCR. Oasl2, Ddx58, Mx1, Stat1, Gbp3, Gbp4, Gbp7, Gbp10, 
Ifih1, lfitm3, Ifi44, Ifit1, Ccl2, Cxcl10, Ly6a and Usp18 were detected by 
relative quantitative real-time PCR to validate the data obtained by 
RNA sequencing analysis. *P < 0.05; **P < 0.01.
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pathological signs [18, 20]. Although it was reported that 
the attenuated Bartha strain does not cause severe brain 
pathology despite viral replication and spread through-
out the brain in chicken embryos [21], our histopathol-
ogy results show much more serious encephalitis in the 
brains of wild-type mice than in those of the  p53−/− mice. 
Compared to the  p53−/− mice, wild-type mice show neu-
ronal degeneration and necrosis in the brain. Notably, 
Purkinje cells in the cerebellum of wild-type mice show 
more obvious shrinkage or necrosis and nuclear disin-
tegration than those in  p53−/− mice. These histolpatho-
logical changes provided morphological data to support 
our observation of serious neurological signs, including 
convulsion, ataxia, and abnormal behavior, in wild-type 
mice after PRV infection. Our findings coincided with 
the conclusion of previous studies that PRV infection 
impairs cerebellar development and differentiation [18, 
20]. Furthermore, two cytokines associated with inflam-
mation, namely IL-6 and TNF-α, in the brains of the 
 p53−/− mice were also significantly lower than those in 
the brains of wild-type mice; this finding coincided with 
the development of encephalitis. These results indicate 
that p53 is required for efficient virulence and replication 
of the virus and for the consequent development of viral 
encephalitis in the brains of mice following intracranial 
inoculation. This requirement of p53 for efficient viral 
replication in the brains of mice is in agreement with 
the findings of our in  vitro study using cell culture, as 
described above. To our knowledge, this is the first report 
showing that p53 plays a positive role in PRV replication 
and pathogenesis both in vitro and in vivo.
We further investigated mRNA profiles in the PRV-
infected  p53−/− and wild-type mice by RNA sequenc-
ing. The gene function analysis shows that differentially 
expressed RNA enrichment was observed in a number 
of the pathways in the host antiviral immune response 
and the inflammatory response processes. The DEG 
primarily enriched the interferon-related pathways, 
including interferon-regulated genes (IRG), interferon-
inducible protein family genes, interferon-inducible 
guanylate-binding protein family genes (Gbp), and inter-
feron-stimulated genes (ISG). Interferon is an important 
antiviral factor of the body [22, 23]. It has been reported 
that alpha/beta interferon receptor deficiency in mice 
significantly enhanced their susceptibility to PRV infec-
tion [24]. In molecular biology, interferon-inducible pro-
tein family genes, namely Gbps and ISG, are key factors 
for protective immunity against microbial and viral path-
ogens [25–27]. The expression of all the above mentioned 
genes was significantly downregulated in the  p53−/− mice 
compared with that in wild-type mice, suggesting that 
the PRV replication progress in the  p53−/− mice was 
inhibited. Moreover, some of the cytokine ligands and 
anti-viral genes show significantly different expression 
between the  p53−/− and wild-type mice. Notably, Cxcl10, 
Oasl1, and Ccl7 in the brain of  p53−/− mice were reduced 
by 133-, 67-, and 42-folds, respectively, compared with 
those in wild-type mice. Previous studies have demon-
strated that Cxcl10 and Ccl7 can offer protective immu-
nity against PRV, while OASL1 deficiency promotes 
antiviral immunity against local mucosal viral infection 
[28–30]. These data corroborate our suggestion that p53 
promotes PRV viral replication and pathogenesis in mice.
In conclusion, this study provides evidence suggesting 
that p53 positively regulates viral replication and patho-
genesis both in  vitro and in  vivo. We demonstrate that 
the host cell protein p53 can be a host cell restriction fac-
tor for PRV infection. Our study offers novel therapeutic 
targets of intrinsic host cell immunity for PRV infection.
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